Faculty & Research

Professor XIE Peng



Name: Xie Peng

Gender: Male

Nationality: China


Email: xiepeng@cqmu.edu.cn


Prof. Xie graduated from the Medical Department of Chongqing Medical University in 1982, after that he studied as a graduate student in the Department of Neurology of the First Affiliated Hospital of Chongqing Medical University from 1982 to 1985.

Working Experience in Recent 5 Years:

2015.1-2018.5 Vice president of Chongqing Medical University

                        Director of the Institute of Neuroscience in Chongqing Medical University

2018.5-2019.7 Director of the Institute of Neuroscience in Chongqing Medical University

2019.7-present Director of NHC Key Laboratory of Diagnosis and Treatment on Brain Functional Diseases, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China

                         Director of the Institute of Neuroscience in Chongqing Medical University


Prof. Xie has dedicated himself to clinical neurology, cerebrovascular disease, central nervous system viral infection, nerve biochemistry, Proteomics Research of Depression, and molecular biology, as well as higher cognitive brain function and clinical neuropsychology research.

He has been in charge of National 973 project (Proteomics and Peptide Research for Depression, 30 million, 2009CB918300), National Key Research and Development project (Construction and Application of Brain Molecular Network Map of Depressive Disorders Based on Protein Machines, 18.61million, 2017YFA0505700), National 863 project (Establishment of molecular biological diagnosis platform for new virus infection, 2.5 million, 2006AA02Z196), international cooperation project of National Natural Science Foundation of China (Intestinal microbial disorder induced depression of molecular mechanism research, 2.4 million, 81820108015). He has been sponsored with 7 programmes by National Natural Science Foundations, and was authorized 7 patents.


National Innovation Award, 2020

Second Prize for the State Scientific and Technological Progress Award, 2017

The First Prize of Chinese Medical Science Award, 2019

The First Prize of Chongqing Scientific and Technological Progress Award, 2019

The Second of Chongqing Scientific and Technological Progress Award, 2004/2006


1. Guowei Wang, Haining Li, Xiaojun Yang, Tao Guo, Libin Wang, Zhijun Zhao, Haifeng Sun, Xiaolin Hou, Xiangchun Ding, Chunyang Dou, Qiaoli Ma, Xiao Yang, Yanbo Wang, Zhao Wang, Luxuan Wang, Jixiang Liu, Zhenhai Wang, Huanyu Wang,Peng Xie. Guillain-Barré Syndrome Outbreak Associated with JEV Infection in China.The New England Journal of Medicine. 2020 Accept (IF:70.67)

2. Cipriani A,Zhou X,Del Giovane C,Hetrick SE,Qin B,Whittington C,Coghill D,Zhang Y,Hazell P,Leucht S,Cuijpers P,Pu J,Cohen D,Ravindran AV,Liu Y,Michael KD,Yang L,Liu L,Xie P. Comparative efficacy and tolerability of antidepressants for major depression in children and adolescents: a network meta-analysisLancet2016;388(10047):881-90. IF: 47.831

3. Zhou X, Hetrick SE., Cuijpers P, Qin B, Barth J, Whittington CJ., Cohen D, Del Giovane C, Liu Y, Michael KD., Zhang Y, Weisz JR.,Xie P. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: a systematic review and network meta-analysis.World Psychiatry. 2015; 14(2):207-22. IF: 20.205

4. Zheng P, Li YF, Wu J, Zhang HP, Huang Y, Tan XM, Pan JX, Duan JJ, Liang WW, Yin BM, Deng FL, Perry SW, Wong ML, Licinio J, Wei H, Yu G,Xie P, Perturbed Microbial Ecology in Myasthenia Gravis: Evidence from the Gut Microbiome and Fecal Metabolome.Advanced Science, 2019; 6(18):1901441, 2019. IF:15.804

5. Zheng P, Yang J, Li Y, Wu J, Liang W, Yin B, Tan X, Huang Y, Chai T, Zhang H, Duan J, Zhou J, Sun Z, Chen X, Marwari S, Lai J, Huang T, Du Y, Zhang P, Perry SW, Wong ML, Licinio J, Hu S,Xie P, Wang G. Gut Microbial Signatures Can Discriminate Unipolar from Bipolar Depression.Adv Sci2020 5;7(7):1902862. IF:15.804

6. Zheng P, Zeng B, Zhou C , Liu M, Fang Z, Xu X, Zeng L, Chen J, Fan S, Du X, Zhang X, Yang D, Yang Y, Meng H, Li W, Melgiri ND, Julio L, Wei H &Xie P. Altered gut microbiome induces depressive-like behaviors through a pathway mediated by the host’s metabolism.Molecular Psychiatry2016 ,21(6):786-96. IF: 13.204

7. Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, Liu Y, Cheng K, Zhou C, Wang H, Zhou X, Gui S, Perry SW, Wong ML, Licinio J, Wei H,Xie P. The gut microbiome from schizophrenia patients modulates the glutamate- glutamine- GABA cycle and schizophrenia-relevant behaviors in mice.Sci Adv 2019;5(2):eaau8317 IF:12.804

8. Zhou X, Liu L, Lan X, Cohen D, Zhang Y, Ravindran AV, Yuan S, Zheng P, Coghill D, Yang L, Hetrick SE, Jiang X, Benoliel JJ, Cipriani A,Xie P. Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents.Molecular Psychiatry, 2019; 24(10):1478–1488. . IF:11.973

9. Zheng P, Wu J, Zeng B, Zhang H, Perry SW, Yin B, Tan X, Chai T, Liang W, Liu M, Chen J, Wong ML, Licinio J, Wei H,Xie P.The gut microbiome modulates gut-brain axis glycerophospho lipid metabolism in a region-specific manner in a non-human primate model of depression,Molecular Psychiatry, 2020 ,doi.org/10.1038/s41380-020-0744-2 IF:11.973

10. Li Q, Zhang G, Huang YJ, Dong MX, Lv FJ, Wei X, Chen JJ, Zhang LJ, Qin XY,Xie P. Blend Sign on Computed Tomography: Novel and Reliable Predictor for Early Hematoma Growth in Patients with Intracerebral Hemorrhage.Stroke. 2015 Aug;46(8):2119-23. IF:5.787